Aegerion Pharmaceuticals, Inc.·4

Sep 18, 4:08 PM ET

Aegerion Pharmaceuticals, Inc. 4

4 · Aegerion Pharmaceuticals, Inc. · Filed Sep 18, 2015

Insider Transaction Report

Form 4
Period: 2015-09-17
Transactions
  • Award

    Stock Option (right to buy)

    2015-09-17+31,18231,182 total
    Exercise: $17.68Exp: 2025-09-17Common Stock (31,182 underlying)
Footnotes (2)
  • [F1]The stock option award has an exercise price equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant.
  • [F2]The 31,182 shares of common stock underlying this option will vest in equal one-third increments on September 17, 2016, September 17, 2017 and September 17, 2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION